Advertisement

Cardiovascular Drugs and Therapy

, Volume 19, Issue 3, pp 173–175 | Cite as

Cough with ACE Inhibitors: A Bigger Problem in Some Racial Groups?

  • M. Gary Nicholls
  • Nigel L. Gilchrist
Editorial

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Reisin L, Schneeweiss A. Spontaneous disappearance of cough induced by angiotensin-converting enzyme inhibitors (captopril or enalapril). Am J Cardiol 1992;70:398–399.CrossRefPubMedGoogle Scholar
  2. Lip GY, Zarifis J, Beevers M, Beevers DG. Duration of cough following cessation of ACE inhibitor therapy. Am J Hypertens 1995;8:98.CrossRefPubMedGoogle Scholar
  3. Malini PL, Strocchi E, Zanardi M, Milani M, Ambrosioni E. Thromboxane antagonism and cough induced by angiotensin-converting-enzyme inhibitor. Lancet 1997;350: 15–18.CrossRefPubMedGoogle Scholar
  4. Umemura K, Nakashima M, Saruta T. Thromboxane A2 synthetase inhibition suppresses cough induced by angiotensin converting enzyme inhibitors. Life Sci 1997;60:1583–1588.CrossRefPubMedGoogle Scholar
  5. Fox AJ, Lalloo UG, Belvisi MG, Bernareggi M, Chung KF, Barnes PJ. Bradykinin-evoked sensitization of airway sensory nerves: A mechanism for ACE-inhibitor cough. Nat Med 1996;2:814–817.CrossRefPubMedGoogle Scholar
  6. Lacourciere Y, Brunner H, Irwin R, et al. Effects of modulators of the renin-angiotensin-aldosterone system on cough. J Hypertens 1994;12:1387–1393.PubMedGoogle Scholar
  7. Sekizawa K, Matsui T, Nakagawa T, Nakayama K, Sasaki H. ACE inhibitors and pneumonia. Lancet 1998;352:1069.CrossRefGoogle Scholar
  8. Okaishi K, Morimoto S, Fukuo K, et al. Reduction of risk of pneumonia associated with use of angiotensin I converting enzyme inhibitors in elderly inpatients. Am J Hypertens 1999;12:778–783.CrossRefPubMedGoogle Scholar
  9. Arai T, Yasuda Y, Takaya T, et al. ACE inhibitors and reduction of the risk of pneumonia in elderly people. Am J Hypertens 2000;13:1050–1051.CrossRefPubMedGoogle Scholar
  10. El Solh AA, Brewer T, Okada M, Bashir O, Gough M. Indicators of recurrent hospitalization for pneumonia in the elderly. J Am Geriatr Soc 2004;52:2010–2015.CrossRefPubMedGoogle Scholar
  11. Chan WK, Chan TYK, Luk WK, Leung VKS, Li TH, Critchley JAJH. A high incidence of cough in Chinese subjects treated with angiotensin converting enzyme inhibitors. Eur J Clin Pharmacol 1993;44:299–300.CrossRefPubMedGoogle Scholar
  12. Woo KS, Norris RM, Nicholls G. Racial difference in incidence of cough with angiotensin-converting enzyme inhibitors (a tale of two cities). Am J Cardiol 1995;75:967–968.CrossRefPubMedGoogle Scholar
  13. Morimoto T, Gandhi TK, Fiskio JM, et al. An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors. J Eval Clin Pract 2004;10:499–509.CrossRefPubMedGoogle Scholar
  14. Morimoto T, Gandhi TK, Fiskio JM, et al. Development and validation of a clinical prediction rule for angiotensin-converting enzyme inhibitor-induced cough. J Gen Intern Med 2004;19:684–691.CrossRefPubMedGoogle Scholar
  15. Yeo WW, Foster G, Ramsay LE. Prevalence of persistent cough during long-term enalapril treatment: Controlled study versus nifedipine. Q J Med 1991;81:763–770.Google Scholar
  16. Os I, Bratland B, Dahlof B, Gisholt K, Syvertsen JO, Tretli S. Female preponderance for lisinopril-induced cough in hypertension. Am J Hypertens 1994;7:1012–1015.PubMedGoogle Scholar
  17. Efstratopoulos AD, Meikopoulos M, Voyaki S. Frequency of cough during therapy with ACE inhibitors in Greek hypertensives. J Hum Hypertens 1993;7:607–609.PubMedGoogle Scholar
  18. Fisman EZ, Grossman E, Motro M, Tenenbaum A. Clinical evidence of dose-dependent interaction between aspirin and angiotensin-converting enzyme inhibitors. J Hum Hypertens 2002;16:379–383.CrossRefPubMedGoogle Scholar
  19. Nicholls MG, Gilchrist NL. Sulindac and cough induced by converting enzyme inhibitors. Lancet 1987;1:872.Google Scholar
  20. Fuller RW. Cough associated with angiotensin-converting enzyme inhibitors. J Hum Hypertens 1989;3:159–161.PubMedGoogle Scholar
  21. Gilchrist NL, Richards AM, March R, Nicholls MG. Effect of sulindac on angiotensin converting enzyme inhibitor-induced cough: Randomised placebo-controlled double-blind cross-over study. J Hum Hypertens 1989;3:451–455.PubMedGoogle Scholar
  22. Fogari R, Zoppi A, Tettamanti F, Malamani GD, Tinelli C, Salvetti A. Effects of nifedipine and indomethacin on cough induced by angiotensin-converting enzyme inhibitors: A double-blind, randomized, cross-over study. J Cardiovasc Pharmacol 1992;19:670–673.PubMedGoogle Scholar
  23. Ohya Y, Kumamoto K, Fujishima M. Effects of crossover application of sulindac and azelastine on enalapril-induced cough. J Hum Hypertens 1992;6:81–82.PubMedGoogle Scholar
  24. Malini PL, Strocchi E, Fiumi N, Ambrosioni E, Ciavarella A. ACE inhibitor-induced cough in hypertensive type 2 diabetic patients. Diabetes Care 1999;22:1586–1587.PubMedGoogle Scholar
  25. Lee Y-J, Tsai JCR. Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor-58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus. Metabolism 2001;50:1346–1350.CrossRefPubMedGoogle Scholar
  26. Ogihara T, Mikami H, Katahira K, Otsuka A. Comparative study of the effects of three angiotensin converting enzyme inhibitors on the cough reflex. Am J Hypertens 1991;4:46S–51S.PubMedGoogle Scholar
  27. Sasaguri M, Ideishi M, Kinoshita A, Arakawa K. Differential inhibition of bradykinin hydrolysis by four ACE Inhibitors: A possible explanation for differences in induced coughing. Hypertens Res 1994;17:253–258.Google Scholar
  28. Yeo WW, Ramsay LE. Persistent dry cough with enalapril: Incidence depends on method used. J Hum Hypertens 1990;4:517–520.PubMedGoogle Scholar
  29. Fletcher AE, Palmer AJ, Bulpitt CJ. Cough with angiotensin converting enzyme inhibitors: How much of a problem? J Hypertens 1994;12(Suppl 2):S43–S47.Google Scholar
  30. Brown NJ, Ray WA, Snowden M, Griffin MR. Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther 1996;60:8–13.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • M. Gary Nicholls
    • 1
  • Nigel L. Gilchrist
    • 2
  1. 1.Department of Internal Medicine, Faculty of Medicine and Health SciencesUAE UniversityAl AinUnited Arab Emirates
  2. 2.Health Care of the ElderlyThe Princess Margaret HospitalChristchurchNew Zealand

Personalised recommendations